NCIC Clinical Trials Group
Abstracts to be Presented at the 55th ASH Annual Meeting and Exposition
New Orleans, LA -- December 7-10, 2013
SATURDAY, December 7th
Program: Oral and Poster Abstracts
Session: 611. Leukemias: Biology, Cytogenetics and Molecular Markers in Diagnosis and Prognosis: Poster I
Trial: ALC.1
Abstract: 1315 Prognostic Significance Of NPM1 mutations In The Absence Of FLT3-ITD in Older Patients With AML: A SWOG Report
Time: 5:30 PM-7:30 PM
Location: Hall E (Ernest N. Morial Convention Center)
Link: https://ash.confex.com/ash/2013/webprogram/Paper57887.html
SUNDAY, December 8th
Program: Oral and Poster Abstracts
Session: 723. Clinical Allogeneic and Autologous Transplantation - Late Complications and Approaches to Disease Recurrence: Relapse after Transplantation - Novel Strategies
Trial: LY.12
Abstract: 155 A Randomized Trial Of Rituximab Vs Observation Following Autologous Stem Cell Transplantation (ASCT) For Relapsed Or Refractory CD20-Positive B Cell Lymphoma: Final Results Of NCIC CTG LY.12
Time: 6:00 PM
Location: Riverside Rooms - R06-R07 (Ernest N. Morial Convention Center)
Link: https://ash.confex.com/ash/2013/webprogram/Paper60435.html
Program: Oral and Poster Abstracts
Session: 615. Acute Myeloid Leukemia: Therapy, excluding Transplantation: Poster II
Trial: ALC.1
Abstract: 2686 Impact Of Cytarabine Dose In The Induction Regimen On The Outcome Of Patients With Newly Diagnosed Acute Myeloid Leukemia With Or Without NPM1 and/Or FLT3 Mutations: A SWOG and MD Anderson Cancer Center Report
Time: 6:30 PM-8:30 PM
Location: Hall E (Ernest N. Morial Convention Center)
Link: https://ash.confex.com/ash/2013/webprogram/Paper58187.html
Program: Oral and Poster Abstracts
Session: 624. Lymphoma: Therapy with Biologic Agents, excluding Pre-Clinical Models: Poster II
Trial: HD.7
Abstract: 3060 The Role Of Body Mass Index In Survival Outcome For Lymphoma Patients: US Intergroup Experience
Time: 6:30 PM-8:30 PM
Location: Hall G (Ernest N. Morial Convention Center)
Link: https://ash.confex.com/ash/2013/webprogram/Paper63545.html
MONDAY, December 9th
Program: Oral and Poster Abstracts
Session: 615. Acute Myeloid Leukemia: Therapy, excluding Transplantation: Antibody-Based Targeted Therapy
Trial: ALC.1
Abstract: 356 The Addition Of Gemtuzumab Ozogamicin (GO) To Induction Chemotherapy Reduces Relapse and Improves Survival In Patients Without Adverse Risk Karyotype: Results Of An Individual Patient Meta-Analysis Of The Five Randomised Trials
Time: 10:45 AM
Location: La Nouvelle Ballroom C (Ernest N. Morial Convention Center)
Link: https://ash.confex.com/ash/2013/webprogram/Paper61280.html
Program: Oral and Poster Abstracts
Session: 615. Acute Myeloid Leukemia: Therapy, excluding Transplantation: Poster III
Trial: ALC.1
Abstract: 3925 Evaluation Of Which Patients Get a Second Course Of 3+7 On Cooperative Group Trials For Newly Diagnosed Acute Myeloid Leukemia: A Report From SWOG
Time: 6:00 PM-8:00 PM
Location: Hall E (Ernest N. Morial Convention Center)
Link: https://ash.confex.com/ash/2013/webprogram/Paper60429.html
Program: Oral and Poster Abstracts
Session: 615. Acute Myeloid Leukemia: Therapy, excluding Transplantation: Poster III
Trial: ALC.1
Abstract: 3924 Prediction Of CR On Reinduction In Patients With Newly Diagnosed Acute Myeloid Leukemia Given Intensive Induction Regimens: A Report From SWOG and Cleveland Clinic
Time: 6:00 PM-8:00 PM
Location: Hall E (Ernest N. Morial Convention Center)
Link: https://ash.confex.com/ash/2013/webprogram/Paper60608.html
Program: Oral and Poster Abstracts
Session: 622. Non-Hodgkin Lymphoma: Biology, excluding Therapy: Poster III
Trial: HD.7
Abstract: 4277 Evaluation Of a Novel 3 Factor Prognostic Score (PS-3) For Patients With Advanced Hodgkin Lymphoma (HL) Treated On US Intergroup E2496
Time: 6:00 PM-8:00 PM
Location: Hall G (Ernest N. Morial Convention Center)
Link: https://ash.confex.com/ash/2013/webprogram/Paper60152.html
Program: Oral and Poster Abstracts
Session: 621. Hodgkin Lymphoma: Biology, excluding Therapy: Poster III
Trial: HD.7
Abstract: 4232 Characterizing The CpG Methylation Of Epstein-Barr Virus DNA In The Plasma Of Patients With Hodgkin Lymphoma and HIV-Associated Burkitt Lymphoma
Time: 6:00 PM-8:00 PM
Location: Hall G (Ernest N. Morial Convention Center)